Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Other Non Operating Income (2021)

Historic Other Non Operating Income for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to $327335.4.

  • ProQR Therapeutics' Other Non Operating Income fell 3644.77% to $327335.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 2280.53%. This contributed to the annual value of -$3.3 million for FY2021, which is 2221.01% up from last year.
  • As of Q3 2025, ProQR Therapeutics' Other Non Operating Income stood at $327335.4, which was down 3644.77% from $217336.2 recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics' Other Non Operating Income registered a high of $1.2 million during Q2 2022, and its lowest value of -$3.0 million during Q2 2021.
  • Over the past 5 years, ProQR Therapeutics' median Other Non Operating Income value was $361246.9 (recorded in 2025), while the average stood at $32400.2.
  • Per our database at Business Quant, ProQR Therapeutics' Other Non Operating Income plummeted by 16103.3% in 2022 and then surged by 19079.41% in 2024.
  • ProQR Therapeutics' Other Non Operating Income (Quarter) stood at -$340903.4 in 2021, then surged by 277.16% to $603956.4 in 2022, then tumbled by 34.57% to $395158.3 in 2023, then soared by 30.34% to $515065.0 in 2024, then crashed by 36.45% to $327335.4 in 2025.
  • Its last three reported values are $327335.4 in Q3 2025, $217336.2 for Q2 2025, and $478607.4 during Q1 2025.